BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

92 related articles for article (PubMed ID: 2481786)

  • 1. Potential use of third-generation beta-blockers in heart failure.
    Chatterjee K
    J Cardiovasc Pharmacol; 1989; 14 Suppl 7():S22-7. PubMed ID: 2481786
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [How and to what extent has beta-blocker treatment been established for chronic heart failure?].
    Yokota Y
    J Cardiol; 1996 Aug; 28(2):99-112. PubMed ID: 8814528
    [TBL] [Abstract][Full Text] [Related]  

  • 3. [Beta-adrenergic blockers in congestive heart failure: pro et contra?].
    Trifunović SL; Pavlović K
    Srp Arh Celok Lek; 1992 Jun; 120 Suppl 4():44-50. PubMed ID: 18193810
    [TBL] [Abstract][Full Text] [Related]  

  • 4. [Therapy of heart failure with beta-blockers?].
    Osterziel KJ; Dietz R
    Z Kardiol; 1997 Jan; 86(1):1-8. PubMed ID: 9133118
    [TBL] [Abstract][Full Text] [Related]  

  • 5. [Sympathetic activity in patients with heart failure due to idiopathic dilated cardiomyopathy: modification by beta receptor blockers--a therapeutic approach?].
    Lohmann FW
    Herz; 1990 Jun; 15(3):202-6. PubMed ID: 1973915
    [TBL] [Abstract][Full Text] [Related]  

  • 6. The cellular and physiologic effects of beta blockers in heart failure.
    Sabbah HN
    Clin Cardiol; 1999 Oct; 22 Suppl 5():V16-20. PubMed ID: 10526699
    [TBL] [Abstract][Full Text] [Related]  

  • 7. [Therapy of chronic heart failure with beta-receptor blockers].
    Böhm M
    Z Kardiol; 1996; 85 Suppl 7():11-21. PubMed ID: 9082679
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Pharmacology of beta-blockers: classical aspects and recent developments.
    Haeusler G
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S1-9. PubMed ID: 11527109
    [TBL] [Abstract][Full Text] [Related]  

  • 9. The role of cardiac beta1- and beta2-adrenoceptor stimulation in heart failure.
    Khamssi M; Brodde OE
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S133-7. PubMed ID: 11527117
    [TBL] [Abstract][Full Text] [Related]  

  • 10. [Role of the L-arginine/nitric oxide system in the action of nebivolol].
    Brodde OE; Philipp T
    Dtsch Med Wochenschr; 2006 Nov; 131(45):2545-50. PubMed ID: 17091442
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Beta-blockers restore calcium release channel function and improve cardiac muscle performance in human heart failure.
    Reiken S; Wehrens XH; Vest JA; Barbone A; Klotz S; Mancini D; Burkhoff D; Marks AR
    Circulation; 2003 May; 107(19):2459-66. PubMed ID: 12743001
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Beta-blocking agents and positive inotropic agents in the therapy of chronic heart failure.
    Erdmann E; Schwinger R; Böhm M
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S138-44. PubMed ID: 11527118
    [TBL] [Abstract][Full Text] [Related]  

  • 13. The neuroendocrine and sympathetic nervous system in congestive heart failure.
    Ferrari R; Ceconi C; Curello S; Visioli O
    Eur Heart J; 1998 Jun; 19 Suppl F():F45-51. PubMed ID: 9651735
    [TBL] [Abstract][Full Text] [Related]  

  • 14. The sympathetic nervous system and ischaemic heart disease.
    Remme WJ
    Eur Heart J; 1998 Jun; 19 Suppl F():F62-71. PubMed ID: 9651738
    [TBL] [Abstract][Full Text] [Related]  

  • 15. The sympathetic nervous system in heart failure physiology, pathophysiology, and clinical implications.
    Triposkiadis F; Karayannis G; Giamouzis G; Skoularigis J; Louridas G; Butler J
    J Am Coll Cardiol; 2009 Nov; 54(19):1747-62. PubMed ID: 19874988
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Beta-blockade treatment in heart failure: the cardiac insufficiency bisoprolol study (CIBIS) project. CIBIS Committees and Investigators. Cardiac Insufficiency Bisoprolol Study.
    Lechat P
    J Cardiovasc Pharmacol; 1990; 16 Suppl 5():S158-63. PubMed ID: 11534531
    [TBL] [Abstract][Full Text] [Related]  

  • 17. [The use of beta blockers in heart failure: clinical studies].
    Cobelli F
    Ital Heart J Suppl; 2000 Aug; 1(8):996-1002. PubMed ID: 10993005
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Celiprolol, a vasodilatory beta-blocker, inhibits pressure overload-induced cardiac hypertrophy and prevents the transition to heart failure via nitric oxide-dependent mechanisms in mice.
    Liao Y; Asakura M; Takashima S; Ogai A; Asano Y; Shintani Y; Minamino T; Asanuma H; Sanada S; Kim J; Kitamura S; Tomoike H; Hori M; Kitakaze M
    Circulation; 2004 Aug; 110(6):692-9. PubMed ID: 15262839
    [TBL] [Abstract][Full Text] [Related]  

  • 19. [New and old beta-blockers in the treatment of heart failure].
    Metra M; Nodari S; Bignotti T; Gnesin P; Trussardi E; Cas LD
    Recenti Prog Med; 2002 Feb; 93(2):113-24. PubMed ID: 11887345
    [TBL] [Abstract][Full Text] [Related]  

  • 20. beta-Blocker therapy for congestive heart failure: clinical considerations.
    Kamath SA; Yancy CW
    Postgrad Med; 2005 Dec; 118(6 Suppl Beta-Blockers):12-20. PubMed ID: 19667706
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 5.